Re: Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study
- PMID: 31922366
- DOI: 10.1002/jmri.27042
Re: Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study
Abstract
5 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2020;52:636-637.
© 2020 International Society for Magnetic Resonance in Medicine.
Comment in
-
Response to LTE "Re: Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study".J Magn Reson Imaging. 2020 Aug;52(2):634-635. doi: 10.1002/jmri.27041. Epub 2020 Jan 10. J Magn Reson Imaging. 2020. PMID: 31922276 No abstract available.
Comment on
-
Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.J Magn Reson Imaging. 2020 May;51(5):1471-1477. doi: 10.1002/jmri.26954. Epub 2019 Oct 30. J Magn Reson Imaging. 2020. PMID: 31665554
References
-
- Topcuoglu ED, Topcuoglu OM, Semiz Oysu A, Bukte Y. Does gadoterate meglumine cause gadolinium retention in the brain of children? A case-control study. J Magn Reson Imaging 2020;52:634-635.
-
- Berger F, Kubik-Huch RA, Niemann T, et al. Gadolinium distribution in cerebrospinal fluid after administration of a gadolinium-based MR contrast agent in humans. Radiology 2018;288:703-709.
-
- Pozeg P, Forget J, Meuli RA, Maeder P. Age, but not repeated exposure to gadoterate meglumine, is associated with T1- and T2-weighted signal intensity changes in the deep brain nuclei of pediatric patients. Invest Radiol 2019;54:537-548.
-
- Flood TF, Bhatt PR, Jensen A, Maloney JA, Stence NV, Mirsky DM. Age-dependent signal intensity changes in the structurally normal pediatric brain on unenhanced T1-weighted MR imaging. AJNR Am J Neuroradiol 2019;40(11):1824-1828. https://doi.org/10.3174/ajnr.A6254.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
